Publications from EAGLE

• Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metsapalu A, Vooder T, Nelis M, Välk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeböller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF Jr, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE. A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet. 2009 Oct 14. [Epub ahead of print]
• Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, Chaturvedi AK, Wacholder S, Landi MT, Lubin JH, Caporaso NE. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One. 2009 Oct 8;4(10):e7380. [PubMed - in process]
• Rotunno M, Yu K, Lubin JH, Consonni D, Pesatori AC, Goldstein AM, Goldin LR, Wacholder S, Welch R, Burdette L, Chanock SJ, Bertazzi PA, Tucker MA, Caporaso NE, Chatterjee N, Bergen AW, Landi MT. Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression. PLoS ONE. 2009; 4(5): e5652.
• Gao Y, Goldstein AM, Consonni D, Pesatori AC, Wacholder S, Tucker MA, Caporaso NE, Goldin L, Landi MT. Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer. 2009; Jul 1;125(1):146-52.
• Lam TK, Cross AJ, Consonni D, Randi G, Bagnardi V, Bertazzi PA, Caporaso NE, Sinha R, Subar AF, Landi MT. Intakes of red meat, processed meat, and meat mutagens increase lung cancer risk. Cancer Res. 2009; Feb 1;69(3):932-9. Epub 2009 Jan 13.
• Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH, Goldin L, Alavanja M, Morgan G, Subar AF, Linnoila I, Previdi F, Corno M, Rubagotti M, Marinelli B, Albetti B, Colombi A, Tucker M, Wacholder S, Pesatori AC, Caporaso NE, Bertazzi PA. Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health. 2008; Jun 6;8:203.
• Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, Murphy SE, Yang P, Pesatori AC, Consonni D, Bertazzi PA, Wacholder S, Shih JH, Caporaso NE, Jen J. Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival. PLoS ONE. 2008; 3(2): e1651

Other Publications Relevant to Lung Cancer

Carcinogenesis

• Hecht S, Tobacco Carcinogens and Lung Cancer, JNCI 1999; 91(14):1194-1210.

Cytogenetics

• Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L, Beheshti J, Lee JC, Naoki K, Richards WG, Sugarbaker D, Chen F, Rubin MA, Jänne PA, Girard L, Minna J, Christiani D, Li C, Sellers WR, Meyerson M. Homozygous deletions and chromosomal amplifications in human lung carcinomas revealed by SNP array analysis. Cancer Research 2005; 65(13):5561-70.
• Mitsuuchi Y and Testa JR. Cytogenetic and Molecular Genetics of Lung Cancer. American Journal of Medical Genetics 2002; 115:183-8.

Epidemiology

• Alberg AJ, Brock MV, Samet JM. Epidemiolgy of Lung Cancer: Looking to the Future. J Clin Oncol 2005; 23(14):3175-85.
• Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, Gupta PC, Hackshaw A, Matos E, Samet J, Sitas F, Smith J, Stayner L, Straif K, Thun MJ, Wichmann HE, Wu AH, Zaridze D, Peto R, Doll R. Tobacco and Cancer: Recent Epidemiological Evidence. J Natl Cancer Inst 2004; 96(1):99-106.

Epigenetics of Lung Cancer

• Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. Promoter Hypermethylation of Multiple Genes in Sputum Preceded Lung Cancer incidence in a High-Risk Cohort. Cancer Research 2006; (66)6:3338-44.

Familiality of Lung Cancer

• Matakidou A, Eisen T and Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005; 93:825-33.
• Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS, Fain P, Schwartz AG, You M, Franklin W, Klein C, Gazdar A, Rothschild H, Mandal D, Coons T, Slusser J, Lee J, Gaba C, Kupert E, Perez A, Zhou X, Zeng D, Liu Q, Zhang Q, Seminara D, Minna J, Anderson MW. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet. September 2004; 75(3):460–74.

Gender

• Patel JD. Lung Cancer in Women. J Clin Oncol. 2005; 23(14):3212-8.

Molecular Biology

• Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, Spitz MR. Cell Cycle Checkpoints, DNA/Damage/Repair, and Lung Cancer Risk. Cancer Research 2005; 65(1):349-363.

Proteomics and Lung Cancer

• Hirano T, and Kato H, Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer. Ann Thorac Cardiovasc Surg. 2006; 12(1):4-9.

• Petricoin E, Wulfkuhle J, Espina V, Liotta LA. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J Proteome Research 2004; 3:209-17.

Screening of Lung Cancer

• International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. New England J Med 2006; 355(17):1763-71.
• Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 35: 99-105.

Staging of Lung Cancer

• Mountain CF. Staging classification of lung cancer. A critical evaluation. Clin Chest Med. 2002 Mar; 23(1):103-21.
• Mountain CF. Revisions of the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717

Therapy of Lung Cancer

• Blons H, Cote JF, Le Corre D, Riquet M, Fabre-Guilevin E, Laurent-Puig P, Danel C. Epidermal Growth Factor Receptor Mutation in Lung Cancer are Linked to Bronchioloalveolar Differentiation. Am J Surg Pathol 2006; Oct; 30(10):1309-15.
• Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA. Erlotinib in lung cancer-molecular and clinical predictors of outcome. New Eng J Med 2005; 353:133-44.
• Sordella R, Bell DW, Haber DA, Settleman J. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 2004; 305:1163-7.

Tobacco and the Genetics of Smoking

• Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 2002; 21:7307-25.
• Bergen AW and Caporaso N. Cigarette Smoking. JNCI 1999; 91(16):1365-75.

This page contains links to PDF files that may be viewed using the free Adobe® Reader®